189 related articles for article (PubMed ID: 32592468)
1. Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's Disease.
Lightner AL; Vogler S; McMichael J; Jia X; Regueiro M; Qazi T; Steele SR
J Crohns Colitis; 2021 Jan; 15(1):24-34. PubMed ID: 32592468
[TBL] [Abstract][Full Text] [Related]
2. Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.
Navaneethan U; Jegadeesan R; Gutierrez NG; Venkatesh PG; Hammel JP; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):e684-91. PubMed ID: 23916526
[TBL] [Abstract][Full Text] [Related]
3. Natural history of low grade dysplasia in patients with primary sclerosing cholangitis and ulcerative colitis.
Venkatesh PG; Jegadeesan R; Gutierrez NG; Sanaka MR; Navaneethan U
J Crohns Colitis; 2013 Dec; 7(12):968-73. PubMed ID: 23433613
[TBL] [Abstract][Full Text] [Related]
4. AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease.
Dorer R; Odze RD
Am J Surg Pathol; 2006 Jul; 30(7):871-7. PubMed ID: 16819330
[TBL] [Abstract][Full Text] [Related]
5. Random biopsies during surveillance colonoscopy increase dysplasia detection in patients with primary sclerosing cholangitis and ulcerative colitis.
Navaneethan U; Kochhar G; Venkatesh PG; Bennett AE; Rizk M; Shen B; Kiran RP
J Crohns Colitis; 2013 Dec; 7(12):974-81. PubMed ID: 23523416
[TBL] [Abstract][Full Text] [Related]
6. Long-term Risk of Advanced Neoplasia After Colonic Low-grade Dysplasia in Patients With Inflammatory Bowel Disease: A Nationwide Cohort Study.
De Jong ME; Van Tilburg SB; Nissen LHC; Kievit W; Nagtegaal ID; Horjus CS; Römkens TEH; Drenth JPH; Hoentjen F; Derikx LAAP
J Crohns Colitis; 2019 Dec; 13(12):1485-1491. PubMed ID: 31175827
[TBL] [Abstract][Full Text] [Related]
7. Clinical implications of low grade dysplasia found during inflammatory bowel disease surveillance: a retrospective study comparing chromoendoscopy and white-light endoscopy.
Ten Hove JR; Mooiweer E; van der Meulen de Jong AE; Dekker E; Ponsioen CY; Siersema PD; Oldenburg B
Endoscopy; 2017 Feb; 49(2):161-168. PubMed ID: 27951611
[No Abstract] [Full Text] [Related]
8. Prospective study of the progression of low-grade dysplasia in ulcerative colitis using current cancer surveillance guidelines.
Zisman TL; Bronner MP; Rulyak S; Kowdley KV; Saunders M; Lee SD; Ko C; Kimmey MB; Stevens A; Maurer J; Brentnall TA
Inflamm Bowel Dis; 2012 Dec; 18(12):2240-6. PubMed ID: 22508402
[TBL] [Abstract][Full Text] [Related]
9. Dysplasia is more common in the distal than proximal colon in ulcerative colitis surveillance.
Goldstone R; Itzkowitz S; Harpaz N; Ullman T
Inflamm Bowel Dis; 2012 May; 18(5):832-7. PubMed ID: 21739534
[TBL] [Abstract][Full Text] [Related]
10. Comparison of high definition with standard white light endoscopy for detection of dysplastic lesions during surveillance colonoscopy in patients with colonic inflammatory bowel disease.
Subramanian V; Ramappa V; Telakis E; Mannath J; Jawhari AU; Hawkey CJ; Ragunath K
Inflamm Bowel Dis; 2013 Feb; 19(2):350-5. PubMed ID: 22552948
[TBL] [Abstract][Full Text] [Related]
11. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
[TBL] [Abstract][Full Text] [Related]
12. Full-Spectrum Endoscopy Improves Surveillance for Dysplasia in Patients With Inflammatory Bowel Diseases.
Leong RW; Ooi M; Corte C; Yau Y; Kermeen M; Katelaris PH; McDonald C; Ngu M
Gastroenterology; 2017 May; 152(6):1337-1344.e3. PubMed ID: 28126349
[TBL] [Abstract][Full Text] [Related]
13. Nearly a Third of High-Grade Dysplasia and Colorectal Cancer Is Undetected in Patients with Inflammatory Bowel Disease.
Eluri S; Parian AM; Limketkai BN; Ha CY; Brant SR; Dudley-Brown S; Efron JE; Fang SG; Gearhart SL; Marohn MR; Meltzer SJ; Bashar S; Truta B; Montgomery EA; Lazarev MG
Dig Dis Sci; 2017 Dec; 62(12):3586-3593. PubMed ID: 28631086
[TBL] [Abstract][Full Text] [Related]
14. Detecting dysplasia using white light endoscopy or chromoendoscopy in ulcerative colitis patients without primary sclerosing cholangitis: A systematic review and meta-analysis.
Azizi S; Al-Rubaye H; Turki MAA; Siddiqui MRS; Shanmuganandan AP; Ehsanullah B; Brar R; Abulafi AM
Int J Surg; 2018 Apr; 52():180-188. PubMed ID: 29462738
[TBL] [Abstract][Full Text] [Related]
15. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis.
Korelitz BI; Sultan K; Kothari M; Arapos L; Schneider J; Panagopoulos G
World J Gastroenterol; 2014 May; 20(17):4980-6. PubMed ID: 24803809
[TBL] [Abstract][Full Text] [Related]
16. Outcome after surveillance of low-grade and indefinite dysplasia in patients with ulcerative colitis.
Pekow JR; Hetzel JT; Rothe JA; Hanauer SB; Turner JR; Hart J; Noffsinger A; Huo D; Rubin DT
Inflamm Bowel Dis; 2010 Aug; 16(8):1352-6. PubMed ID: 20027656
[TBL] [Abstract][Full Text] [Related]
17. Low-grade dysplasia in ulcerative colitis: risk factors for developing high-grade dysplasia or colorectal cancer.
Choi CH; Ignjatovic-Wilson A; Askari A; Lee GH; Warusavitarne J; Moorghen M; Thomas-Gibson S; Saunders BP; Rutter MD; Graham TA; Hart AL
Am J Gastroenterol; 2015 Oct; 110(10):1461-71; quiz 1472. PubMed ID: 26416190
[TBL] [Abstract][Full Text] [Related]
18. Endoscopic screening for dysplasia and mucosal aneuploidy in adolescents and young adults with childhood onset colitis.
Markowitz J; McKinley M; Kahn E; Stiel L; Rosa J; Grancher K; Daum F
Am J Gastroenterol; 1997 Nov; 92(11):2001-6. PubMed ID: 9362180
[TBL] [Abstract][Full Text] [Related]
19. Assessment of peri-polyp biopsy specimens of flat mucosa in patients with inflammatory bowel disease.
Krugliak Cleveland N; Huo D; Sadiq F; Sofia MA; Marks J; Cohen RD; Hanauer SB; Turner J; Hart J; Rubin DT
Gastrointest Endosc; 2018 May; 87(5):1304-1309. PubMed ID: 29307473
[TBL] [Abstract][Full Text] [Related]
20. Weak Cytotoxic T Cells Activation Predicts Low-Grade Dysplasia Persistence in Ulcerative Colitis.
Kotsafti A; DʼIncà R; Scarpa M; Fassan M; Angriman I; Mescoli C; Bortoli N; Brun P; Bardini R; Rugge M; Savarino E; Zingone F; Castoro C; Castagliuolo I; Scarpa M
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00061. PubMed ID: 31343468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
